MEDx Investigator awarded NIH Director's New Innovator Awards

Congratulations to MEDx Investigator Mike Tadross on being selected to receive NIH Director's New Innovator Awards. The Award is part of the High-Risk, High-Reward Research program managed by the Common Fund and addresses two important goals: stimulating highly innovative research that has the potential for significant impact and supporting promising New and Early Stage Investigators. As part of NIH's commitment to increasing opportunities for new scientists, the award supports a small group of exceptionally creative New and Early Stage Investigators who propose bold new approaches with the potential to produce a major impact on a broad area of biomedical or behavioral research.